Compare Nerdwallet Inc (NRDS) vs Organon & Co. Common Stock (OGN) Price & Performance

NerdWallet (NRDS) trades at $9.64, down 1.83% today, with strong technical momentum showing 16 bullish signals versus 7 bearish. The company demonstrates solid fundamental improvement with revenue growing from $539M in 2022 to $837M in 2025, while turning profitable with net income reaching $49M. Recent earnings show mixed results with Q2 2026 missing expectations but Q1 and Q4 2025 beating estimates. Valuation metrics appear attractive with P/E of 10.61 and P/S of 0.79, suggesting potential undervaluation relative to growth prospects.

The outlook remains positive with analyst consensus favoring Buy ratings (66.7%) and projecting 27.9% upside potential. Key opportunities include continued revenue growth and margin expansion, while risks involve competitive pressures in financial guidance services and dependence on organic search traffic. The company's improving cash flow generation and strong profitability metrics (18.16% ROE) support the bullish case, though investors should monitor execution on Q3 2026 earnings expectations of $0.35 EPS.

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.